Molecular analysis of drug resistant TB [3]

Thorax

Volumn 57, Issue 6, 2002, Pages 562-563

  Melzer, Mark ^a   Brown, T J ^a   French, G L ^a   Dickens, A ^a   McHugh, T D ^a   Bagg, L R ^a   Storring, R A ^a   Lacey, S ^a   Melzer, M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; CLINICAL ARTICLE; GENE MUTATION; GENOTYPE; HUMAN; LETTER; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 0036286465     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.6.562     Document Type: Letter

References (7)

1. Summary of a report of the working party on tuberculosis of the London group of Consultants in Communicable Disease Control
2. Tuberculosis in African born adults: Can we improve clinical practice?
3. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from New York City
4. Genotypes associated with isoniazid resistance in Mycobacterium tuberculosis isolates seen at a London teaching hospital
5. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardised methodology
6. Mutations in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
7. Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations